MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,828,000 | +57.8% | 111,058 | +0.0% | 0.07% | +53.2% |
| Q2 2020 | $3,694,000 | +35.6% | 111,038 | +10.8% | 0.05% | +9.3% |
| Q1 2020 | $2,725,000 | +61.1% | 100,198 | +16.9% | 0.04% | +95.5% |
| Q4 2019 | $1,691,000 | +72.2% | 85,729 | +13.1% | 0.02% | +69.2% |
| Q3 2019 | $982,000 | +135.5% | 75,827 | +126.2% | 0.01% | +85.7% |
| Q2 2019 | $417,000 | -13.5% | 33,527 | +1.0% | 0.01% | -22.2% |
| Q1 2019 | $482,000 | +36.2% | 33,201 | +3.4% | 0.01% | +28.6% |
| Q4 2018 | $354,000 | -47.3% | 32,101 | +25.6% | 0.01% | -36.4% |
| Q3 2018 | $672,000 | +29.7% | 25,554 | +0.7% | 0.01% | +22.2% |
| Q2 2018 | $518,000 | +15.1% | 25,374 | +2.3% | 0.01% | 0.0% |
| Q1 2018 | $450,000 | +113.3% | 24,804 | +63.4% | 0.01% | +80.0% |
| Q4 2017 | $211,000 | -24.1% | 15,184 | +0.9% | 0.01% | -64.3% |
| Q3 2017 | $278,000 | +25.2% | 15,054 | +14.2% | 0.01% | -6.7% |
| Q2 2017 | $222,000 | +133.7% | 13,184 | +84.6% | 0.02% | +114.3% |
| Q1 2017 | $95,000 | -8.7% | 7,140 | +2.9% | 0.01% | -30.0% |
| Q4 2016 | $104,000 | – | 6,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $45,360,000 | 2.38% |
| Palo Alto Investors LP | 1,757,122 | $22,772,000 | 1.52% |
| Greencape Capital Pty Ltd | 270,280 | $3,503,000 | 1.24% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $12,960,000 | 1.19% |
| Ghost Tree Capital, LLC | 350,000 | $4,536,000 | 1.16% |
| Perceptive Advisors | 2,905,000 | $37,649,000 | 1.01% |
| Eventide Asset Management | 1,236,000 | $16,019,000 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 80,000 | $1,036,000 | 0.48% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 832,627 | $10,791,000 | 0.29% |
| Rock Springs Capital Management LP | 400,000 | $5,184,000 | 0.21% |